Lifestance Health (LFST) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Lifestance Health · Health Care · ref. ETF XLV · 50 calls · price $12.3
What the company does: LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States.
📈 Lifestance Health (LFST) stock price
$12.3+124.5% over range
Aug 28, 25low $4.81 · high $12.83Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
67% recommend buying · 6 analysts
📊 JPI status : Lifestance Health has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 LFST price target & analyst consensus — price $12.30
The price target · all analysts combined (6 targets)
Highest target · 1 firm of 6$18+46.3%
Median target · of 6 targets$13+5.7%
Lowest target · 1 firm of 6$9-26.8%
Current price$12.3
Where these 6 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
583%
$13 ↔ $18
Below
117%
$9
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 6 ratings (last 6 months)
Strong Buy00%
Buy467%
Hold233%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 LFST price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on LFST most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in LFST? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Lifestance Health? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on LFST
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Barclays ↗ | 100% | +12.5% | 3 |
| UBS ↗ | 67% | +35.6% | 3 |
| Cowen & Co. | 67% | -9.6% | 3 |
| Morgan Stanley ↗ | 40% | -14.6% | 5 |
📊 What $1,000 invested in Lifestance Health would be worth › open the full page
In short — $1,000 invested in Lifestance Health 10 years ago would be worth $450 today, i.e. -15%/yr on average. Best year: 2023 (+59%), worst: 2022 (-48%). Price performance, excluding dividends.
If I'd invested $1,000 in Lifestance Health
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,376 | +38% |
| 3 years ago | $2,184 | +118% |
| 5 years ago | $450 | -55% |
Return by year (Lifestance Health)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +55% | $1,550 (+55%) |
| 2025 | -11% | $1,376 (+38%) |
| 2024 | +0% | $1,378 (+38%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Lifestance Health
Loading news…
📋 All analyst calls on LFST
Filtered on — · ✕ show all
▲ Buy · 🎯$18
Price at call : $12.83 — upside +40%
Today : $12.3 — upside +46%
🎯 on LFST : no call matured yet · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Aug 19, 27
matures : Aug 19, 27
■ Neutral neutral · not a buy · 🎯$13
Price at call : $12.55 — gap to target +4%
Today : $12.3 — gap to target +6%
🎯 on LFST : no call matured yet · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Aug 14, 27
matures : Aug 14, 27
▲ Buy · 🎯$16
Price at call : $10.84 — upside +48%
Today : $12.3 — upside +30%
🎯 on LFST : no call matured yet · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
▲ Buy · 🎯$15
Price at call : $10.9 — upside +38%
Today : $12.3 — upside +22%
🎯 on LFST : no call matured yet · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Jul 24, 27
matures : Jul 24, 27
Canaccord Genuity ↗
Jul 21, 26
▲ Buy · 🎯$13
Price at call : $11.45 — upside +14%
Today : $12.3 — upside +6%
🎯 on LFST : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Jul 21, 27
matures : Jul 21, 27
▲ Overweight · 🎯$13
Price at call : $10.79 — upside +20%
Today : $12.3 — upside +6%
🎯 on LFST : 100% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
▲ Overweight · 🎯$13
Price at call : $10.88 — upside +19%
Today : $12.3 — upside +6%
🎯 on LFST : 0% (1 call matured) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
Goldman Sachs ↗
Jun 5, 26
■ Neutral neutral · not a buy · 🎯$9
Price at call : $7.41 — gap to target +21%
Today : $12.3 — gap to target -27%
🎯 on LFST : 0% (1 call matured) · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Jun 5, 27
matures : Jun 5, 27
See the other 42 calls, newest to oldest
■ Neutral neutral · not a buy · 🎯$9
Price at call : $7.65 — gap to target +18%
Today : $12.3 — gap to target -27%
🎯 on LFST : no call matured yet · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
▲ Buy · 🎯$12
Price at call : $7.7 — upside +56%
Today : $12.3 — upside -2%
🎯 on LFST : no call matured yet · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
▲ Overweight · 🎯$9
Price at call : $6.91 — upside +30%
Today : $12.3 — upside -27%
🎯 on LFST : 100% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Mar 6, 27
matures : Mar 6, 27
Canaccord Genuity ↗
Feb 26, 26
▲ Buy · 🎯$10
Price at call : $7.24 — upside +38%
Today : $12.3 — upside -19%
🎯 on LFST : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Buy · 🎯$12
Price at call : $7.24 — upside +66%
Today : $12.3 — upside -2%
🎯 on LFST : 67% (3 calls matureds) · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Overweight · 🎯$9
Price at call : $7.24 — upside +24%
Today : $12.3 — upside -27%
🎯 on LFST : 0% (1 call matured) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Buy · 🎯$11
Price at call : $7.18 — upside +53%
Today : $12.3 — upside -11%
🎯 on LFST : no call matured yet · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
▲ Buy · 🎯$10
Price at call : $6.91 — upside +45%
Today : $12.3 — upside -19%
🎯 on LFST : no call matured yet · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Dec 12, 26
matures : Dec 12, 26
▲ Overweight · 🎯$8
Price at call : $6.75 — upside +19%
Today : $12.3 — upside -35%
🎯 on LFST : 100% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
BMO Capital ↗
Nov 13, 25
▲ Outperform · 🎯$8
Price at call : $6.31 — upside +27%
Today : $12.3 — upside -35%
🎯 on LFST : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
▲ Buy · 🎯$10
Price at call : $6.43 — upside +56%
Today : $12.3 — upside -19%
🎯 on LFST : 67% (3 calls matureds) · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
▲ Buy · 🎯$9
Price at call : $6.25 — upside +44%
Today : $12.3 — upside -27%
🎯 on LFST : no call matured yet · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Buy · 🎯$9
Price at call : $4.57 — upside +97%
Today : $12.3 — upside -27%
Expected +97% · Actual +160% · Reason (≥ +15%) : ✓ Yes
🎯 on LFST : 67% (3 calls matureds) · 📊 on Health : 50% · +2.7% (74 calls)
+160.4%
stock +160% · XLV +29%
matured Aug 8, 26
▲ Buy · 🎯$8.5
Price at call : $6.06 — upside +40%
Today : $12.3 — upside -31%
Expected +40% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on LFST : 67% (3 calls matureds) · 📊 on Health : 50% · +2.7% (74 calls)
+25.6%
stock +26% · XLV +13%
matured May 27, 26
▲ Overweight · 🎯$9
Price at call : $6.91 — upside +30%
Today : $12.3 — upside -27%
Expected +30% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on LFST : 0% (1 call matured) · 📊 on Health : 25.2% · -18.3% (107 calls)
-6.1%
stock -6% · XLV +8%
matured Apr 8, 26
Canaccord Genuity ↗
Apr 3, 25
▲ Buy · 🎯$8
Price at call : $6.74 — upside +19%
Today : $12.3 — upside -35%
Expected +19% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on LFST : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
-5.0%
stock -5% · XLV +2%
matured Apr 3, 26
Goldman Sachs ↗
Dec 16, 24
▲ Buy · 🎯$10
Price at call : $7.75 — upside +29%
Today : $12.3 — upside -19%
Expected +29% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on LFST : 0% (1 call matured) · 📊 on Health : 51% · +5.1% (102 calls)
-11.2%
stock -11% · XLV +11%
matured Dec 16, 25
▼ Underweight · 🎯$7
Price at call : $7.39 — upside -5%
Today : $12.3 — upside -43%
Expected -5% · Actual -12% · Reason (≤ −15%) : ✗ No
🎯 on LFST : 100% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
+12.4%
stock -12% · XLV +1%
matured Nov 11, 25
■ Neutral neutral · not a buy · 🎯$7.5
Price at call : $5.84 — gap to target +28%
Today : $12.3 — gap to target -39%
🎯 on LFST : 67% (3 calls matureds) · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Aug 15, 25
matures : Aug 15, 25
▼ Underweight · 🎯$6
Price at call : $5.6 — upside +7%
Today : $12.3 — upside -51%
Expected +7% · Actual -18% · Reason (≤ −15%) : ✓ Yes
🎯 on LFST : 100% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
+18.4%
stock -18% · XLV -13%
matured Aug 9, 25
Morgan Stanley ↗
Apr 22, 24
▲ Overweight · 🎯$10
Price at call : $6.11 — upside +64%
Today : $12.3 — upside -19%
Expected +64% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on LFST : 50% (4 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+4.3%
stock +4% · XLV -4%
matured Apr 22, 25
▲ Buy · 🎯$9
Price at call : $7.24 — upside +24%
Today : $12.3 — upside -27%
Expected +24% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on LFST : 100% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)
+8.8%
stock +9% · XLV +2%
matured Mar 6, 25
Goldman Sachs ↗
Mar 4, 24
■ Neutral neutral · not a buy · 🎯$9
Price at call : $7.38 — gap to target +22%
Today : $12.3 — gap to target -27%
🎯 on LFST : 0% (1 call matured) · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Mar 4, 25
matures : Mar 4, 25
▼ Underweight · 🎯$8
Price at call : $8.35 — upside -4%
Today : $12.3 — upside -35%
Expected -4% · Actual -7% · Reason (≤ −15%) : ✗ No
🎯 on LFST : 100% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
+6.7%
stock -7% · XLV +3%
matured Feb 28, 25
Goldman Sachs ↗
Nov 22, 23
■ Neutral neutral · not a buy · 🎯$8
Price at call : $6.4 — gap to target +25%
Today : $12.3 — gap to target -35%
🎯 on LFST : 0% (1 call matured) · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Nov 21, 24
matures : Nov 21, 24
■ Neutral neutral · not a buy · 🎯$8
Price at call : $6.2 — gap to target +29%
Today : $12.3 — gap to target -35%
🎯 on LFST : no call matured yet · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Nov 16, 24
matures : Nov 16, 24
■ Neutral neutral · not a buy · 🎯$10
Price at call : $8.16 — gap to target +23%
Today : $12.3 — gap to target -19%
🎯 on LFST : no call matured yet · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Aug 9, 24
matures : Aug 9, 24
Morgan Stanley ↗
Jul 13, 23
▲ Overweight · 🎯$10
Price at call : $9.33 — upside +7%
Today : $12.3 — upside -19%
Expected +7% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on LFST : 50% (4 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-41.3%
stock -41% · XLV +12%
matured Jul 12, 24
Goldman Sachs ↗
May 19, 23
■ Neutral neutral · not a buy · 🎯$9
Price at call : $8.36 — gap to target +8%
Today : $12.3 — gap to target -27%
🎯 on LFST : 0% (1 call matured) · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : May 18, 24
matures : May 18, 24
Morgan Stanley ↗
May 11, 23
▲ Overweight · 🎯$10
Price at call : $8.24 — upside +21%
Today : $12.3 — upside -19%
Expected +21% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on LFST : 50% (4 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-16.8%
stock -17% · XLV +8%
matured May 10, 24
Morgan Stanley ↗
Jan 6, 23
▲ Overweight · 🎯$8
Price at call : $4.72 — upside +69%
Today : $12.3 — upside -35%
Expected +69% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on LFST : 50% (4 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+60.0%
stock +60% · XLV +3%
matured Jan 6, 24
Goldman Sachs ↗
Nov 15, 22
■ Neutral neutral · not a buy · 🎯$8
Price at call : $5.88 — gap to target +36%
Today : $12.3 — gap to target -35%
🎯 on LFST : 0% (1 call matured) · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Nov 15, 23
matures : Nov 15, 23
Cowen & Co.
Nov 14, 22
▲ Outperform · 🎯$8
Price at call : $6.12 — upside +31%
Today : $12.3 — upside -35%
Expected +31% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on LFST : 67% (3 calls matureds) · 📊 unranked overall
+1.5%
stock +1% · XLV -4%
matured Nov 14, 23
Cowen & Co.
Aug 22, 22
▲ Outperform · 🎯$10
Price at call : $6.79 — upside +47%
Today : $12.3 — upside -19%
Expected +47% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on LFST : 67% (3 calls matureds) · 📊 unranked overall
+16.5%
stock +16% · XLV +2%
matured Aug 22, 23
Morgan Stanley ↗
May 10, 22
■ Equal-Weight neutral · not a buy · 🎯$8
Price at call : $5.82 — gap to target +37%
Today : $12.3 — gap to target -35%
🎯 on LFST : 50% (4 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : May 10, 23
matures : May 10, 23
Goldman Sachs ↗
Mar 21, 22
■ Neutral neutral · not a buy · 🎯$10
Price at call : $8.94 — gap to target +12%
Today : $12.3 — gap to target -19%
🎯 on LFST : 0% (1 call matured) · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Mar 21, 23
matures : Mar 21, 23
■ Neutral neutral · not a buy · 🎯$10
Price at call : $9.56 — gap to target +5%
Today : $12.3 — gap to target -19%
🎯 on LFST : 67% (3 calls matureds) · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Mar 17, 23
matures : Mar 17, 23
Morgan Stanley ↗
Dec 17, 21
■ Equal-Weight neutral · not a buy · 🎯$10
Price at call : $9.66 — gap to target +4%
Today : $12.3 — gap to target -19%
🎯 on LFST : 50% (4 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Dec 17, 22
matures : Dec 17, 22
■ Neutral neutral · not a buy · 🎯$12
Price at call : $9.73 — gap to target +23%
Today : $12.3 — gap to target -2%
🎯 on LFST : no call matured yet · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Nov 9, 22
matures : Nov 9, 22
Cowen & Co.
Sep 10, 21
▲ Outperform · 🎯$18
Price at call : $16.26 — upside +11%
Today : $12.3 — upside +46%
Expected +11% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on LFST : 67% (3 calls matureds) · 📊 unranked overall
-46.7%
stock -47% · XLV -1%
matured Sep 10, 22
Morgan Stanley ↗
Aug 16, 21
■ Equal-Weight neutral · not a buy · 🎯$16
Price at call : $13.83 — gap to target +16%
Today : $12.3 — gap to target +30%
🎯 on LFST : 50% (4 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Aug 16, 22
matures : Aug 16, 22
Frequently asked questions
Should I buy Lifestance Health stock?
This isn't buy advice. For Lifestance Health, the analyst consensus is "Buy", with an average price target of $13.00 (+6% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Lifestance Health). We show the numbers — you decide.
Is it too late to buy Lifestance Health? How high can it go?
The most bullish analyst target on Lifestance Health is $18.00 (+46% above today's price); the average is $13.00. That's the upside they see. Check how reliable those analysts have actually been on Lifestance Health on our site before trusting it.
Is Lifestance Health still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 4 analysts have a real record on Lifestance Health, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Lifestance Health? The case for and against
The arguments for and against, one by one, from the numbers: why invest in LFST (and why hesitate).
What has Lifestance Health's past performance been?
Historical returns and a "how much if I had invested" calculator: LFST performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX